Terms: = Breast cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Prognosis
16 results:
1. The efficacy and safety of Xihuang Pill/capsule in adjuvant treatment of breast cancer: A systematic review and meta-analysis of 26 randomized controlled trials.
Ge A; Yang K; Deng X; Zhao D; Ge J; Liu L
J Ethnopharmacol; 2022 Sep; 295():115357. PubMed ID: 35545184
[TBL] [Abstract] [Full Text] [Related]
2. Correlations of breast cancer fhit gene with the incidence and prognosis of breast cancer.
Fu Y; Shan X; Song W; Xu K; Jiao C; Zhang Q
J BUON; 2019; 24(1):40-47. PubMed ID: 30941950
[TBL] [Abstract] [Full Text] [Related]
3. Home-based multidimensional survivorship programmes for breast cancer survivors.
Cheng KKF; Lim YTE; Koh ZM; Tam WWS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
[TBL] [Abstract] [Full Text] [Related]
4. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological significance and prognostic value of leukemia-related protein 16 expression in invasive ductal breast carcinoma.
Zhao P; Lu Y; Han W
Cancer Sci; 2010 Oct; 101(10):2262-8. PubMed ID: 20649898
[TBL] [Abstract] [Full Text] [Related]
6. Specific 50'CpG island methylation signatures of fhit and p16 genes and their potential diagnostic relevance in Indian breast cancer patients.
Naqvi RA; Hussain A; Raish M; Noor A; Shahid M; Sarin R; Kukreti H; Khan NJ; Ahmad S; Deo SV; Husain SA; Pasha ST; Basir SF; Shukla NK
DNA Cell Biol; 2008 Sep; 27(9):517-25. PubMed ID: 18593338
[TBL] [Abstract] [Full Text] [Related]
7. fhit expression protects against HER2-driven breast tumor development: unraveling the molecular interconnections.
Bianchi F; Tagliabue E; Ménard S; Campiglio M
Cell Cycle; 2007 Mar; 6(6):643-6. PubMed ID: 17374991
[TBL] [Abstract] [Full Text] [Related]
8. [Expression of the genes fhit, Bcl-2 and Bax in breast infiltrating ductal carcinoma and clinicopathological significance thereof].
Wang ZB; Zhao P; Liu M; Li XH
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2171-6. PubMed ID: 17064501
[TBL] [Abstract] [Full Text] [Related]
9. Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.
Letessier A; Garrido-Urbani S; Ginestier C; Fournier G; Esterni B; Monville F; Adélaïde J; Geneix J; Xerri L; Dubreuil P; Viens P; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Lopez M; Chaffanet M
Oncogene; 2007 Jan; 26(2):298-307. PubMed ID: 16819513
[TBL] [Abstract] [Full Text] [Related]
10. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract] [Full Text] [Related]
11. Loss of fhit protein expression is a marker of adverse evolution in good prognosis localized breast cancer.
Ginestier C; Bardou VJ; Popovici C; Charafe-Jauffret E; Bertucci F; Geneix J; Adélaïde J; Chaffanet M; Hassoun J; Viens P; Jacquemier J; Birnbaum D
Int J Cancer; 2003 Dec; 107(5):854-62. PubMed ID: 14566838
[TBL] [Abstract] [Full Text] [Related]
12. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
[TBL] [Abstract] [Full Text] [Related]
14. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract] [Full Text] [Related]
15. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
Kleer CG; Giordano TJ; Braun T; Oberman HA
Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
[TBL] [Abstract] [Full Text] [Related]
16. Allelic deletion analysis of the fhit gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract] [Full Text] [Related]